Detalhe da pesquisa
1.
Long-term efficacy of a hepatitis E vaccine.
N Engl J Med
; 372(10): 914-22, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738667
2.
Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial.
Lancet Reg Health West Pac
; 34: 100731, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37283969
3.
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial.
Lancet Infect Dis
; 23(11): 1313-1322, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37475116
4.
Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial.
Hum Vaccin Immunother
; 18(6): 2092363, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834812
5.
Efficacy, safety, and immunogenicity of an Escherichia coli-produced Human Papillomavirus (16 and 18) L1 virus-like-particle vaccine: end-of-study analysis of a phase 3, double-blind, randomised, controlled trial.
Lancet Infect Dis
; 22(12): 1756-1768, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36037823
6.
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.
Emerg Microbes Infect
; 10(1): 365-375, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33583360
7.
Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.
Hum Vaccin Immunother
; 16(7): 1630-1635, 2020 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32544361
8.
Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial.
Hum Vaccin Immunother
; 16(7): 1636-1644, 2020 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31770068
9.
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women.
Sci China Life Sci
; 63(4): 582-591, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231780
10.
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
J Natl Cancer Inst
; 112(2): 145-153, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31086947
11.
Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65â¯years.
Vaccine
; 37(32): 4581-4586, 2019 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31262585
12.
[Expression and purification of Toxoplasma gondii GRA4 gene in prokaryotic system].
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi
; 23(6): 419-23, 2005 Dec 30.
Artigo
em Zh
| MEDLINE | ID: mdl-16566210
13.
Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial.
Vaccine
; 33(32): 3940-6, 2015 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26100924
14.
[High efficiency expression and antigenicity analysis of the SAG2 gene from Toxoplasma gondii RH strain].
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi
; 22(4): 231-4, 2004 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-15587158
15.
Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination.
Hum Vaccin Immunother
; 10(3): 740-6, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24384608
16.
Immune response in Balb/c mice induced by recombinant spike protein of severe acute respiratory syndrome coronavirus.
Chin Med J (Engl)
; 118(10): 857-60, 2005 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15989769
17.
[Hepatitis E in children].
Zhonghua Liu Xing Bing Xue Za Zhi
; 34(5): 536-8, 2013 May.
Artigo
em Zh
| MEDLINE | ID: mdl-24016451
18.
[Establishment and application of human papillomavirus type 16 pseudovirions neutralization assay].
Sheng Wu Gong Cheng Xue Bao
; 22(6): 990-5, 2006 Nov.
Artigo
em Zh
| MEDLINE | ID: mdl-17168325